AI assistant
BioSenic SA — AGM Information 2022
Jun 13, 2022
3920_rns_2022-06-13_7a16d6e6-7fe0-44f7-a37c-fbab57db52ad.pdf
AGM Information
Open in viewerOpens in your device viewer
BONE THERAPEUTICS Public limited liability company Rue Granbonpré 11, Building H 1435 Mont-Saint-Guibert RLE : Walloon Brabant VAT : 0882.015.654
(the "Company")
INFORMATION CONCERNING THE RIGHT OF SHAREHOLDERS TO ASK QUESTIONS ON THE OCCASION OF THE EXTRAORDINARY GENERAL MEETING OF THE COMPANY TO BE HELD BEFORE A NOTARY ON 13 JULY 2022 AS OF 11:00 AM (BELGIAN TIME) AT RUE DU FORT 24, 6000 CHARLEROI, BELGIUM
In accordance with article 7:139 of the Belgian Code on Companies and Associations, shareholders have the right to ask questions in writing to the directors prior to the extraordinary general meeting that will be held on 13 July 2022.
The exercise of this right is subject to the fulfilment of the following two conditions:
- being a shareholder of the Company at the record date (on 29 June 2022 at midnight (Belgian time)); and
- having informed the Company of the intent to participate in the extraordinary general meeting, pursuant to the provisions set out in the convocation notice.
These questions can be submitted prior to the extraordinary general meeting by email to [email protected], or by mail to the attention of Bone Therapeutics, Mr. Benjamin D'Haese and Mrs. Myriam Piscitello, Rue Granbonpré 11, Building H, 1435 Mont-Saint-Guibert, Belgium. They must be received by the Company on 7 July 2022 at 05.00 pm (Belgian time) at the latest.
During the extraordinary general meeting, the directors will answer the questions that will have been asked by the shareholders, in writing before the meeting (or orally during the meeting), concerning their reports or the items on the agenda, insofar as the communication of certain data or facts is not of such a nature as to prejudice the Company or the confidentiality undertakings entered into by the Company or its directors. The statutory auditor also answers questions put by the shareholders, at the meeting or in writing prior to the meeting, concerning his report.
The directors may give a global answer to different questions on the same subject.